Literature DB >> 34789505

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.

Stella Talic1,2, Shivangi Shah3, Holly Wild3,4, Danijela Gasevic3,5, Ashika Maharaj3, Zanfina Ademi3,2, Xue Li5,6, Wei Xu5, Ines Mesa-Eguiagaray5, Jasmin Rostron5, Evropi Theodoratou5,7, Xiaomeng Zhang5, Ashmika Motee5, Danny Liew3,2, Dragan Ilic3.   

Abstract

OBJECTIVE: To review the evidence on the effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality.
DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Embase, CINAHL, Biosis, Joanna Briggs, Global Health, and World Health Organization COVID-19 database (preprints). ELIGIBILITY CRITERIA FOR STUDY SELECTION: Observational and interventional studies that assessed the effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality. MAIN OUTCOME MEASURES: The main outcome measure was incidence of covid-19. Secondary outcomes included SARS-CoV-2 transmission and covid-19 mortality. DATA SYNTHESIS: DerSimonian Laird random effects meta-analysis was performed to investigate the effect of mask wearing, handwashing, and physical distancing measures on incidence of covid-19. Pooled effect estimates with corresponding 95% confidence intervals were computed, and heterogeneity among studies was assessed using Cochran's Q test and the I2 metrics, with two tailed P values.
RESULTS: 72 studies met the inclusion criteria, of which 35 evaluated individual public health measures and 37 assessed multiple public health measures as a "package of interventions." Eight of 35 studies were included in the meta-analysis, which indicated a reduction in incidence of covid-19 associated with handwashing (relative risk 0.47, 95% confidence interval 0.19 to 1.12, I2=12%), mask wearing (0.47, 0.29 to 0.75, I2=84%), and physical distancing (0.75, 0.59 to 0.95, I2=87%). Owing to heterogeneity of the studies, meta-analysis was not possible for the outcomes of quarantine and isolation, universal lockdowns, and closures of borders, schools, and workplaces. The effects of these interventions were synthesised descriptively.
CONCLUSIONS: This systematic review and meta-analysis suggests that several personal protective and social measures, including handwashing, mask wearing, and physical distancing are associated with reductions in the incidence covid-19. Public health efforts to implement public health measures should consider community health and sociocultural needs, and future research is needed to better understand the effectiveness of public health measures in the context of covid-19 vaccination. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020178692. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34789505      PMCID: PMC9423125          DOI: 10.1136/bmj-2021-068302

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


Introduction

The impact of SARS-CoV-2 on global public health and economies has been profound.1 As of 14 October 2021, there were 239 007 759 million cases of confirmed covid-19 and 4 871 841 million deaths with covid-19 worldwide.2 A variety of containment and mitigation strategies have been adopted to adequately respond to covid-19, with the intention of deferring major surges of patients in hospitals and protecting the most vulnerable people from infection, including elderly people and those with comorbidities.3 Strategies to achieve these goals are diverse, commonly based on national risk assessments that include estimation of numbers of patients requiring hospital admission and availability of hospital beds and ventilation support. Globally, vaccination programmes have proved to be safe and effective and save lives.4 5 Yet most vaccines do not confer 100% protection, and it is not known how vaccines will prevent future transmission of SARS-CoV-2,6 given emerging variants.7 8 9 The proportion of the population that must be vaccinated against covid-19 to reach herd immunity depends greatly on current and future variants.10 This vaccination threshold varies according to the country and population’s response, types of vaccines, groups prioritised for vaccination, and viral mutations, among other factors.6 Until herd immunity to covid-19 is reached, regardless of the already proven high vaccination rates,11 public health preventive strategies are likely to remain as first choice measures in disease prevention,12 particularly in places with a low uptake of covid-19 vaccination. Measures such as lockdown (local and national variant), physical distancing, mandatory use of face masks, and hand hygiene have been implemented as primary preventive strategies to curb the covid-19 pandemic.13 Public health (or non-pharmaceutical) interventions have been shown to be beneficial in fighting respiratory infections transmitted through contact, droplets, and aerosols.14 15 Given that SARS-CoV-2 is highly transmissible, it is a challenge to determine which measures might be more effective and sustainable for further prevention. Substantial benefits in reducing mortality were observed in countries with universal lockdowns in place, such as Australia, New Zealand, Singapore, and China. Universal lockdowns are not, however, sustainable, and more tailored interventions need to be considered; the ones that maintain social lives and keep economies functional while protecting high risk individuals.16 17 Substantial variation exists in how different countries and governments have applied public health measures,18 and it has proved a challenge for assessing the effectiveness of individual public health measures, particularly in policy decision making.19 Previous systematic reviews on the effectiveness of public health measures to treat covid-19 lacked the inclusion of analytical studies,20 a comprehensive approach to data synthesis (focusing only on one measure),21 a rigorous assessment of effectiveness of public health measures,22 an assessment of the certainty of the evidence,23 and robust methods for comparative analysis.24 To tackle these gaps, we performed a systematic review of the evidence on the effectiveness of both individual and multiple public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality. When feasible we also did a critical appraisal of the evidence and meta-analysis.

Methods

This systematic review and meta-analysis were conducted in accordance with PRISMA25 (supplementary material 1, table 1) and with PROSPERO (supplementary material 1, table 2).

Eligibility criteria

Articles that met the population, intervention, comparison, outcome, and study design criteria were eligible for inclusion in this systematic review (supplementary material 1, table 3). Specifically, preventive public health measures that were tested independently were included in the main analysis. Multiple measures, which generally contain a “package of interventions”, were included as supplementary material owing to the inability to report on the individual effectiveness of measures and comparisons on which package led to enhanced outcomes. The public health measures were identified from published World Health Organization sources that reported on the effectiveness of such measures on a range of communicable diseases, mostly respiratory infections, such as influenza. Given that the scientific community is concerned about the ability of the numerous mathematical models, which are based on assumptions, to predict the course of virus transmission or effectiveness of interventions,26 this review focused only on empirical studies. We excluded case reports and case studies, modelling and simulation studies, studies that provided a graphical summary of measures without clear statistical assessments or outputs, ecological studies that provided a descriptive summary of the measures without assessing linearity or having comparators, non‐empirical studies (eg, commentaries, editorials, government reports), other reviews, articles involving only individuals exposed to other pathogens that can cause respiratory infections, such as severe acute respiratory syndrome or Middle East respiratory syndrome, and articles in a language other than English.

Information sources

We carried out electronic searches of Medline, Embase, CINAHL (Cumulative Index to Nursing and Allied Health Literature, Ebsco), Global Health, Biosis, Joanna Briggs, and the WHO COVID-19 database (for preprints). A clinical epidemiologist (ST) developed the initial search strategy, which was validated by two senior medical librarians (LR and MD) (supplementary material 1, table 4). The updated search strategy was last performed on 7 June 2021. All citations identified from the database searches were uploaded to Covidence, an online software designed for managing systematic reviews,27 for study selection.

Study selection

Authors ST, DG, SS, AM, ET, JR, XL, WX, IME, and XZ independently screened the titles and abstracts and excluded studies that did not match the inclusion criteria. Discrepancies were resolved in discussion with the main author (ST). The same authors retrieved full text articles and determined whether to include or exclude studies on the basis of predetermined selection criteria. Using a pilot tested data extraction form, authors ST, SS, AM, JR, XL, WX, AM, IME, and XZ independently extracted data on study design, intervention, effect measures, outcomes, results, and limitations. ST, SS, AM, and HW verified the extracted data. Table 5 in supplementary material 1 provides the specific criteria used to assess study designs. Given the heterogeneity and diversity in how studies defined public health measures, we took a common approach to summarise evidence of these interventions (supplementary material 1, table 6).

Risk of bias within individual studies

SS, JR, XL, WX, IME, and XZ independently assessed risk of bias for each study, which was cross checked by ST and HW. For non-interventional observational studies, a ROBINS-I (risk of bias in non-randomised studies of interventions) risk of bias tool was used.28 For interventional studies, a revised tool for assessing risk of bias in randomised trials (RoB 2) tool was used.29 Reviewers rated each domain for overall risk of bias as low, moderate, high, or serious/critical.

Data synthesis

The DerSimonian and Laird method was used for random effects meta-analysis, in which the standard error of the study specific estimates was adjusted to incorporate a measure of the extent of variation, or heterogeneity, among the effects observed for public health measures across different studies. It was assumed that the differences between studies are a result of different, yet related, intervention effects being estimated. If fewer than five studies were included in meta-analysis, we applied a recommended modified Hartung-Knapp-Sidik-Jonkman method.30

Statistical analysis

Because of the differences in the effect metrics reported by the included studies, we could only perform quantitative data synthesis for three interventions: handwashing, face mask wearing, and physical distancing. Odds ratios or relative risks with corresponding 95% confidence intervals were reported for the associations between the public health measures and incidence of covid-19. When necessary, we transformed effect metrics derived from different studies to allow pooled analysis. We used the Dersimonian Laird random effects model to estimate pooled effect estimates along with corresponding 95% confidence intervals for each measure. Heterogeneity among individual studies was assessed using the Cochran Q test and the I2 test.31 All statistical analyses were conducted in R (version 4.0.3) and all P values were two tailed, with P=0.05 considered to be significant. For the remaining studies, when meta-analysis was not feasible, we reported the results in a narrative synthesis.

Public and patient involvement

No patients or members of the public were directly involved in this study as no primary data were collected. A member of the public was, however, asked to read the manuscript after submission.

Results

A total of 36 729 studies were initially screened, of which 36 079 were considered irrelevent. After exclusions, 650 studies were eligible for full text review and 72 met the inclusion criteria. Of these studies, 35 assessed individual interventions and were included in the final synthesis of results (fig 1) and 37 assessed multiple interventions as a package and are included in supplementary material 3, tables 2 and 3. The included studies comprised 34 observational studies and one interventional study, eight of which were included in the meta-analysis.
Fig 1

Flow of articles through the review. WHO=World Health Organization

Flow of articles through the review. WHO=World Health Organization

Risk of bias

According to the ROBINS-I tool,28 the risk of bias was rated as low in three studies,32 33 34 moderate in 24 studies,35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 and high to serious in seven studies.59 60 61 62 63 64 65 One important source of serious or critical risk of bias in most of the included studies was major confounding, which was difficult to control for because of the novel nature of the pandemic (ie, natural settings in which multiple interventions might have been enforced at once, different levels of enforcement across regions, and uncaptured individual level interventions such as increased personal hygiene). Variations in testing capacity and coverage, changes to diagnostic criteria, and access to accurate and reliable outcome data on covid-19 incidence and covid-19 mortality, was a source of measurement bias for numerous studies (fig 2). These limitations were particularly prominent early in the pandemic, and in low income environments.47 52 62 63 65 The randomised controlled trial66 was rated as moderate risk of bias according to the ROB-2 tool. Missing data, losses to follow-up, lack of blinding, and low adherence to intervention all contributed to the reported moderate risk. Tables 1 and 2 in supplementary material 2 summarise the risk of bias assessment for each study assessing individual measures.
Fig 2

Summary of risk of bias across studies assessing individual measures using risk of bias in non-randomised studies of interventions (ROBINS-I) tool

Summary of risk of bias across studies assessing individual measures using risk of bias in non-randomised studies of interventions (ROBINS-I) tool

Study characteristics

Studies assessing individual measures

Thirty five studies provided estimates on the effectiveness of an individual public health measures. The studies were conducted in Asia (n=11), the United States (n=9), Europe (n=7), the Middle East (n=3), Africa (n=3), South America (n=1), and Australia (n=1). Thirty four of the studies were observational and one was a randomised controlled trial. The study designs of the observational studies comprised natural experiments (n=11), quasi-experiments (n=3), a prospective cohort (n=1), retrospective cohorts (n=8), case-control (n=2), and cross sectional (n=9). Twenty six studies assessed social measures,32 34 35 37 38 39 40 41 42 44 46 47 48 52 53 55 56 57 58 59 60 61 63 64 65 67 12 studies assessed personal protective measures,36 43 45 49 50 57 58 60 63 66 68 three studies assessed travel related measures,54 58 62 and one study assessed environmental measures57 (some interventions overlapped across studies). The most commonly measured outcome was incidence of covid-19 (n=18), followed by SARS-CoV-2 transmission, measured as reproductive number, growth number, or epidemic doubling time (n=13), and covid-19 mortality (n=8). Table 1 in supplementary material 3 provides detailed information on each study.

Effects of interventions

Personal protective measures

Handwashing and covid-19 incidence—Three studies with a total of 292 people infected with SARS-CoV-2 and 10 345 participants were included in the analysis of the effect of handwashing on incidence of covid-19.36 60 63 Overall pooled analysis suggested an estimated 53% non-statistically significant reduction in covid-19 incidence (relative risk 0.47, 95% confidence interval 0.19 to 1.12, I2=12%) (fig 3). A sensitivity analysis without adjustment showed a significant reduction in covid-19 incidence (0.49, 0.33 to 0.72, I2=12%) (fig 4). Risk of bias across the three studies ranged from moderate36 60 to serious or critical63 (fig 2).
Fig 3

Meta-analysis of evidence on association between handwashing and incidence of covid-19 using modified Hartung-Knapp-Sidik-Jonkman adjusted random effect model

Fig 4

Meta-analysis of evidence on association between handwashing and incidence of covid-19 using unadjusted random effect model

Meta-analysis of evidence on association between handwashing and incidence of covid-19 using modified Hartung-Knapp-Sidik-Jonkman adjusted random effect model Meta-analysis of evidence on association between handwashing and incidence of covid-19 using unadjusted random effect model Mask wearing and covid-19 incidence—Six studies with a total of 2627 people with covid-19 and 389 228 participants were included in the analysis examining the effect of mask wearing on incidence of covid-19 (table 1).36 43 57 60 63 66 Overall pooled analysis showed a 53% reduction in covid-19 incidence (0.47, 0.29 to 0.75), although heterogeneity between studies was substantial (I2=84%) (fig 5). Risk of bias across the six studies ranged from moderate36 57 60 66 to serious or critical43 63 (fig 2).
Table 1

Study characteristics and main results from studies that assessed individual personal protective and environmental measures

Reference, countryStudy designPublic health measureSample sizeOutcome measureStudy durationEffect estimates: conclusionsRisk of bias
Doung-Ngern et al,63 ThailandCase-controlHandwashing211 cases, 839 controlsIncidence1-31 Mar 2020Regular handwashing: adjusted odds ratio 0.34 (95% confidence interval 0.13 to 0.87): associated with lower risk of SARS-CoV-2*Serious or critical
Lio et al,36 ChinaCase-controlHandwashing24 cases, 1113 controlsIncidence17 Mar-15 Apr 2020Adjusted odds ratio 0.30 (95% confidence interval 0.11 to 0.80): reduction in odds of becoming infectious*Moderate
Xu et al,60 ChinaCross sectional comparativeHandwashingn=8158Incidence22 Feb-5 Mar 2020Relative risk 3.53 (95% confidence interval 1.53 to 8.15): significantly increased risk of infection with no handwashing*Moderate
Bundgaard et al,66 DenmarkRandomised controlledMask wearing2392 cases, 2470 controlsIncidenceApr and May 2020Odds ratio 0.82 (95% confidence interval 0.54 to 1.23): 46% reduction to 23% increase in infection*Moderate
Doung-Ngern et al,63 ThailandCase-controlMask wearing211 cases, 839 controlsIncidence1-31 Mar 2020Adjusted odds ratio 0.23 (95% confidence interval 0.09 to 1.60): associated with lower risk of SARS-CoV-2 infection*Serious or critical
Lio et al,36 ChinaCase-controlMask wearing24 cases, 1113 controlsIncidence17 Mar-15 Apr 2020Odds ratio 0.30 (95% confidence interval 0.10 to 0.86): 70% risk reduction*Moderate
Xu et al,60 ChinaCross sectional comparativeMask wearing8158 peopleIncidence22 Feb-5 Mar 2020Relative risk 12.38 (95% confidence interval 5.81 to 26.36): significantly increased risk of infection*Moderate
Krishnamachari et al,43 USNatural experimentMask wearing50 statesIncidence (cumulative rate)Apr 20203-6 months, adjusted odds ratio 1.61 (95% confidence interval 1.23 to 2.10): >6 months, 2.16 (1.64 to 2.88): higher incidence rate with later mask mandate than with mask mandate in first month*Serious or critical
Wang et al,57 ChinaRetrospective cohortMask wearing335 peopleIncidence (assessed as attack rate†)28 Feb-27 Mar 2020Odds ratio 0.21 (95% confidence interval 0.06 to 0.79): 79% reduction in transmission of SARS-CoV-2*Moderate
Cheng et al,68 ChinaLongitudinal comparativeMask wearing (South Korea v HKSAR)961 cases (HKSAR), average control not availableIncidence31 Dec 2019-8 Apr 2020Incidence rate 49.6% (South Korea) v 11.8% (HKSAR) P <0.001: 37.8% less SARS-CoV-2 cases*Moderate
Leffler et al,49 USNatural experimentMask wearing200 countriesMortality (per capita)Jan-9 May 2020No masks: mortality rate 61.9% (95% confidence interval 37.0% to 91.0%); masks: 16.2% (−14.4% to 57.4%): 45.7% fewer mortality*Moderate
Lyu et al,50 USNatural experimentMask wearing15 statesCase growth rate31 Mar-22 May 2020Mandatory mask wearing: case growth rate 2%: 2% decrease in daily covid-19 growth rate at ≥21 days (P<0.05)*Moderate
Rader et al,45 USCross sectionalMask wearing378 207 peopleR03 Jun-27 JulAdjusted odds ratio 3.53 (95% confidence interval 2.03 to 6.43): 10% increase in self-reported mask wearing was associated with an increased odds of transmission control*Moderate
Liu et al,58 USNatural experimentMask wearing50 statesRt21 Jan-31 May 2020Risk ratio 0.71 (95% confidence interval 0.58 to 0.75): 29% reduction in Rt*Moderate
Wang et al,57 ChinaRetrospective cohortChlorine or ethanol based disinfectant335 peopleIncidence (attack rate†)28 Feb-27 Mar 2020Odds ratio 0.23 (95% confidence interval 0.07 to 0.84): 77% reduction in transmission of SARS-CoV-2*Moderate

HKSAR=Hong Kong Special Administrative Region of China; R0=reproductive number; Rt=time varying reproductive number.

Interpretation of findings as reported in the original manuscript.

Percentage of individuals who tested positive over a specified period.

Fig 5

Meta-analysis of evidence on association between mask wearing and incidence of covid-19 using unadjusted random effect model

Study characteristics and main results from studies that assessed individual personal protective and environmental measures HKSAR=Hong Kong Special Administrative Region of China; R0=reproductive number; Rt=time varying reproductive number. Interpretation of findings as reported in the original manuscript. Percentage of individuals who tested positive over a specified period. Meta-analysis of evidence on association between mask wearing and incidence of covid-19 using unadjusted random effect model Mask wearing and transmission of SARS-CoV-2, covid-19 incidence, and covid-19 mortality—The results of additional studies that assessed mask wearing (not included in the meta-analysis because of substantial differences in the assessed outcomes) indicate a reduction in covid-19 incidence, SARS-CoV-2 transmission, and covid-19 mortality. Specifically, a natural experiment across 200 countries showed 45.7% fewer covid-19 related mortality in countries where mask wearing was mandatory (table 1).49 Another natural experiment study in the US reported a 29% reduction in SARS-CoV-2 transmission (measured as the time varying reproductive number Rt) (risk ratio 0.71, 95% confidence interval 0.58 to 0.75) in states where mask wearing was mandatory.58 A comparative study in the Hong Kong Special Administrative Region reported a statistically significant lower cumulative incidence of covid-19 associated with mask wearing than in selected countries where mask wearing was not mandatory (table 1).68 Similarly, another natural experiment involving 15 US states reported a 2% statistically significant daily decrease in covid-19 transmission (measured as case growth rate) at ≥21 days after mask wearing became mandatory,50 whereas a cross sectional study reported that a 10% increase in self-reported mask wearing was associated with greater odds for control of SARS-CoV-2 transmission (adjusted odds ratio 3.53, 95% confidence interval 2.03 to 6.43).45 The five studies were rated at moderate risk of bias (fig 2).

Environmental measures

Disinfection in household and covid-19 incidence

Only one study, from China, reported the association between disinfection of surfaces and risk of secondary transmission of SARS-CoV-2 within households (table 1).57 The study assessed disinfection retrospectively by asking participants about their “daily use of chlorine or ethanol-based disinfectant in households,” and observed that use of disinfectant was 77% effective at reducing SARS-CoV-2 transmission (odds ratio 0.23, 95% confidence interval 0.07 to 0.84). The study did not collect data on the concentration of the disinfectant used by participants and was rated at moderate risk of bias (fig 2).

Social measures

Physical distancing and covid-19 incidence

Five studies with a total of 2727 people with SARS-CoV-2 and 108 933 participants were included in the analysis that examined the effect of physical distancing on the incidence of covid-19.37 53 57 60 63 Overall pooled analysis indicated a 25% reduction in incidence of covid-19 (relative risk 0.75, 95% confidence interval 0.59 to 0.95, I2=87%) (fig 6). Heterogeneity among studies was substantial, and risk of bias ranged from moderate37 53 57 60 to serious or critical63(fig 2).
Fig 6

Meta-analysis of evidence on association between physical distancing and incidence of covid-19 using unadjusted random effect model

Meta-analysis of evidence on association between physical distancing and incidence of covid-19 using unadjusted random effect model

Physical distancing and transmission of SARS-CoV-2 and covid-19 mortality

Studies that assessed physical distancing but were not included in the meta-analysis because of substantial differences in outcomes assessed, generally reported a positive effect of physical distancing (table 2). A natural experiment from the US reported a 12% decrease in SARS-CoV-2 transmission (relative risk 0.88, 95% confidence interval 0.86 to 0.89),40 and a quasi-experimental study from Iran reported a reduction in covid-19 related mortality (β −0.07, 95% confidence interval −0.05 to −0.10; P<0.001).47 Another comparative study in Kenya also reported a reduction in transmission of SARS-CoV-2 after physical distancing was implemented, reporting 62% reduction in overall physical contacts (reproductive number pre-intervention was 2.64 and post-intervention was 0.60 (interquartile range 0.50 to 0.68)).61 These three studies were rated at moderate risk of bias40 61 to serious or critical risk of bias47 (fig 2).
Table 2

Study characteristics and main results from studies assessing individual social measures

Reference, countryStudy designPublic health measureSample sizeOutcomeStudy durationEffect estimates: conclusionsRisk of bias
Jarvis et al,65 UKCross sectionalStay at home or isolation1356 casesR0Feb-24 Mar 2020R0: pre-intervention 3.6, post-intervention 0.60 (95% confidence interval 0.37 to 0.89): 3.0 R0 decreaseSerious or critical
Khosravi et al,55 IranCross sectionalStay at home or isolation993 casesR020 Feb-01 Apr 2020R0: pre-intervention 2.70 (95% confidence interval 2.10 to 3.40), post-intervention 1.13 (1.03 to 1.25): 1.5 R0 decreaseModerate
Dreher et al,41 USRetrospective cohortStay at home or isolation49 states and territoriesR0NSOdds ratio 0.07 (95% confidence interval 0.01 to 0.37): decrease in odds of having a positive R0 result*Low
Liu et al,58 USNatural experimentStay at home or isolation50 statesRt21 Jan-31 May 2020Risk ratio 0.49 (95% confidence interval 0.43 to 0.54): contributed about 51% to reduction in Rt*Moderate
Alfano et al,52 ItalyNatural experimentLockdown202 countries, 22 018 peopleIncidence22 Jan-10 May 2020β coefficient −235.8 (standard error −11.04), P<0.01Serious or critical
Thayer et al,56 IndiaQuasi-experimentalLockdownNSIncidence (% median)2 Mar-1 Sept 2020Incidence rate: pre-lockdown 15.8% (95% confidence interval 7.0% to 20.2%), post-lockdown 5.0% (4.7% to 5.4%): 10.8% reduction in average incidence rate*Moderate
Pillai et al,46 South AfricaRetrospective cohortLockdown162 528Attack rate†5 Mar-30 JuneAttack rate: pre-lockdown 18.5%, full lockdown 4.1%: 14.1% reduction in risk*Moderate
Siedner et al,35 USNatural experimentLockdown45 statesCase growth rate, mortality growth rate10-25 Mar 2020Case growth rate 0.9% decrease (95% confidence interval 1.40% to 0.4%)/day (after 4 days)*; mortality growth rate 2.0% mortality decrease (−3.0% to 0.9%)/day*Moderate
Silva et al,42 BrazilQuasi-experimentalLockdownNationwideMortality5-30 Mar 2020Post-intervention changes in mortality, São Luís (β coefficient −0.13, P<0.001), Recife (β coefficient −0.06, P<0.001), Belém (β coefficient −0.10, P<0.001), Fortaleza (β coefficient −0.09, P<0.001): 27.4% average difference in mortalityModerate
Tobias et al,38 SpainNatural experimentLockdownSpain and ItalyMortality24 Feb-5 Apr 2020Mortality rates: Italy pre-intervention −32.8 (95% confidence interval 21.0 to 44.6), Italy post-intervention −0.2 (−1.5 to 1.0), Spain pre-intervention 59.3 (23.0 to 95.2), Spain post-intervention −1.8 (−5.0 to 3.1): beneficial effect in both countries*Moderate
Wang et al,69 ChinaRetrospective cohortLockdownNationwideR010 Jan-16 Feb 2020R0: pre-intervention 4.95 (95% confidence interval 4.26 to 5.67), post-intervention 0.98 (0.96 to 1.03): 3.97 decreaseLow
Guzzetta et al,39 ItalyLongitudinal comparativeLockdownNationwideR010-25 Mar 2020R0: pre-intervention 2.03, 3 weeks 0.76 (95% confidence interval 0.67 to 0.85): 1.27 decreaseLow
Basu et al,64 IndiaRetrospective cohortLockdownNationwideR024 Mar-31 May 2020R0: pre-intervention 3.36 (95% confidence interval 3.03 to 3.71), post-intervention 1.27 (1.26 to 1.28): 2.09 decreaseModerate
Guo et al,40 USNatural experimentLockdown50 states and one territory (Virgin Islands)Rt29 Jan-31 Jul 2020Relative risk 0.89 (95% confidence interval 0.88 to 0.91): associated with a 11% decrease in risk of Rt*Moderate
Al-Tawfiq et al,34 Saudi ArabiaProspective cohortQuarantine1928 casesIncidence14 Mar-6 JunIncidence rate: 4 weeks 5.9%, 8 weeks 1.0%, 13 weeks 0%: 4.9% decrease at 8 weeksLow
Vaman et al,59 IndiaRetrospective cohortQuarantine179 casesRisk of transmission24 Mar-30 Apr 2020Odds ratio 14.44 (95% confidence interval 2.42 to 86.17), relative risk 11.85 (95% confidence interval 2.91 to 48.23): >14 times higher risk without quarantine compared with strict quarantine.* Significant risk of transmission*Moderate
Auger et al,48 USLongitudinal comparativeSchool closureNationwideIncidence, mortality (adjusted relative change)9 Mar-7 May 2020Incidence −62% (95% confidence interval −49% to −71%), mortality rate −58% (95% confidence interval −46% to −68%): decreased covid-19 incidence and mortality*Moderate
Vlachos et al,32 SwedenCross sectional comparativeSchool closureTeachers and parents, number not specifiedIncidence25 Mar-1 Apr 2020Odds ratio 2.01 (95% confidence interval 1.52 to 2.67): teachers in lower secondary schools twice as likely to become infected with SARS-CoV-2 than teachers in upper secondary school*Moderate
Iwata et al,44 JapanNatural experimentSchool closureNot specifiedIncidence27-Feb 31 Mar 2020α coefficient 0.08 (95% confidence interval −0.36 to 0.65): no decrease in incidence of SARS-CoV-2‡Moderate
Liu et al,58 USNatural experimentSchool closure50 statesRt21 Jan-31 May 2020Risk ratio 0.90 (95% confidence interval 0.86 to 0.93): contributed about 10% to reduction in Rt*Moderate
Guo et al,40 USNatural experimentSchool closure50 states and one territory (Virgin Islands)Rt29 Jan-31 July 2020Relative risk 0.87 (95% confidence interval 0.86 to 0.89): associated with 13% decrease in risk of Rt*Moderate
Liu et al,58 USNatural experimentBusiness closure50 statesRt21 Jan-31 May 2020Risk ratio 0.84 (95% confidence interval 0.79 to 0.90): contributed about 26% reduction in Rt*Moderate
Guo et al,40 USNatural experimentBusiness closure50 states and one territory (Virgin Islands)Rt29 Jan-31 July 2020Relative risk 0.88 (95% confidence interval 0.86 to 0.89): associated with 12% decrease in risk of Rt*Moderate
Voko et al,53 EuropeNatural experimentPhysical distancing28 countriesIncidence1 Feb-18 Apr 2020Incidence rate ratio 1.23 (95% confidence interval 1.19 to 1.28), 0.98 (0.97 to 0.99): 26% decrease in incidence*Moderate
Van den Berg et al,37 USRetrospective cohortPhysical distancing99 390 staffIncidence (adjusted)24 Sep 2020-27 Jan 2021≥3 v ≥6 feet adjusted incidence rate ratio 1.01 (95% confidence interval 0.75 to 1.36), larger physical distancing not associated with lower rates of SARS-CoV-2*‡Moderate
Xu et al,60ChinaCross sectional comparativePhysical distancing8158 peopleIncidence22 Feb-5 Mar 2020Relative risk 2.63 (95% confidence interval 1.48 to 4.67): significantly increased risk of infection*Moderate
Doung-Ngern et al,63 ThailandCase-controlPhysical distancing211 cases, 839 controlsIncidence1-31 Mar 2020>1m physical distance adjusted odds ratio 0.15; 95% confidence interval 0.04 to 0.63)): associated with lower risk of SARS-CoV-2 infection*Serious or critical
Wang et al,57 ChinaRetrospective cohortPhysical distancing335 peopleIncidence (proportions assessed as attack rate†)28 Feb-27 Mar 2020Odds ratio 18.26 (95% confidence interval 3.93 to 84.79): risk of household transmission was 18 times higher with frequent daily close contact with the primary case*Moderate
Alimohamadi et al,47 IranQuasi-experimentalPhysical distancingNSIncidence, mortality20 Feb-13 May 2020Incidence β coefficient −1.70 (95% confidence interval −2.3 to 1.1), mortality β coefficient −0.07 (−0.05 to −0.10): reduced incidence and mortality*Serious or critical
Quaife et al,61 AfricaCross-sectional comparativePhysical distancing237 casesR01 -31 May 2020R0: pre-intervention 2.64, post-intervention 0.60 (interquartile range 0.50-0.68): 2.04 decrease in R0Moderate
Guo et al,40 USNatural experimentPhysical distancing50 states and one territory (Virgin Islands)Rt29 Jan-31 Jul 2020Relative risk 0.88 (95% confidence interval 0.86 to 0.89): associated with a 12% decrease in risk of Rt*Moderate

R0=reproductive number; Rt=time varying reproductive number.

Interpretation of findings as reported in the original manuscript.

Percentage of individuals who tested positive over a specified period.

Not an effective intervention.

Study characteristics and main results from studies assessing individual social measures R0=reproductive number; Rt=time varying reproductive number. Interpretation of findings as reported in the original manuscript. Percentage of individuals who tested positive over a specified period. Not an effective intervention.

Stay at home or isolation and transmission of SARS-CoV-2

All the studies that assessed stay at home or isolation measures reported reductions in transmission of SARS-CoV-2 (table 2). A retrospective cohort study from the US reported a significant reduction in the odds of having a positive reproductive number (R0) result (odds ratio 0.07, 95% confidence interval 0.01 to 0.37),41 and a natural experiment reported a 51% reduction in time varying reproductive number (Rt) (risk ratio 0.49, 95% confidence interval 0.43 to 0.54).58 A study from the UK reported a 74% reduction in the average daily number of contacts observed for each participant and estimated a decrease in reproductive number: the reproductive number pre-intervention was 3.6 and post-intervention was 0.60 (95% confidence interval 0.37 to 0.89).65 Similarly, an Iranian study projected the reproductive number using serial interval distribution and the number of incidence cases and found a significant decrease: the reproductive number pre-intervention was 2.70 and post-intervention was 1.13 (95% confidence interval 1.03 to 1.25).55 Three of the studies were rated at moderate to serious or critical risk of bias,55 58 65 and one study was rated at low risk of bias41 (fig 2).

Quarantine and incidence and transmission of SARS-CoV-2

Quarantine was assessed in two studies (table 2).34 59 A prospective cohort study from Saudi Arabia reported a 4.9% decrease in the incidence of covid-19 at eight weeks after the implementation of quarantine.34 This study was rated at low risk of bias (fig 2). A retrospective cohort study from India reported a 14 times higher risk of SARS-CoV-2 transmission associated with no quarantine compared with strict quarantine (odds ratio 14.44, 95% confidence interval 2.42 to 86.17).59 This study was rated at moderate risk of bias (fig 2).

School closures and covid-19 incidence and covid-19 mortality

Two studies assessed the effectiveness of school closures on transmission of SARS-CoV-2, incidence of covid-19, or covid-19 mortality (table 2).44 48 A US population based longitudinal study reported on the effectiveness of state-wide closure of primary and secondary schools and observed a 62% decrease (95% confidence interval −49% to −71%) in incidence of covid-19 and a 58% decrease (−46% to−68%) in covid-19 mortality.48 Conversely, a natural experiment from Japan reported no effect of school closures on incidence of covid-19 (α coefficient 0.08, 95% confidence interval −0.36 to 0.65).44 Both studies were rated at moderate risk of bias (fig 2).

School closures and transmission of SARS-CoV-2

Two natural experiments from the US reported a reduction in transmission (ie, reproductive number); with one study reporting a reduction of 13% (relative risk 0.87, 95% confidence interval 0.86 to 0.89)40 and another reporting a 10% (0.90, 0.86 to 0.93) reduction (table 2).58 A Swedish study reported an association between school closures and a small increase in confirmed SARS-CoV-2 infections in parents (odds ratio 1.17, 95% confidence interval 1.03 to 1.32), but observed that teachers in lower secondary schools were twice as likely to become infected than teachers in upper secondary schools (2.01, 1.52 to 2.67).32 All three studies were rated at moderate risk of bias (fig 2).

Business closures and transmission of SARS-CoV-2

Two natural experiment studies assessed business closures across 50 US states and reported reductions in transmission of SARS-CoV-2 (table 2).40 58 One of the studies observed a significant reduction in transmission of 12% (relative risk 0.88, 95% confidence interval 0.86 to 0.89)40 and the other reported a significant 16% (risk ratio 0.84, 0.79 to 0.90) reduction.58 Both studies were rated at moderate risk of bias (fig 2).

Lockdown and incidence of covid-19

A natural experiment involving 202 countries suggested that countries that implemented universal lockdown had fewer new cases of covid-19 than countries that did not (β coefficient −235.8 (standard error −11.04), P<0.01) (table 2).52 An Indian quasi-experimental study reported a 10.8% reduction in incidence of covid-19 post-lockdown,56 whereas a South African retrospective cohort study observed a 14.1% reduction in risk after implementation of universal lockdown (table 2).46 These studies were rated at high risk of bias52 and moderate risk of bias46 56 (fig 2).

Lockdown and covid-19 mortality

The three studies that assessed universal lockdown and covid-19 mortality generally reported a decrease in mortality (table 2).35 38 42 A natural experiment study involving 45 US states reported a decrease in covid-19 related mortality of 2.0% (95% confidence interval −3.0% to 0.9%) daily after lockdown had been made mandatory.35 A Brazilian quasi-experimental study reported a 27.4% average difference in covid-19 related mortality rates in the first 25 days of lockdown.42 In addition, a natural experiment study reported about 30% and 60% reductions in covid-19 related mortality post-lockdown in Italy and Spain over four weeks post-intervention, respectively.38 All three studies were rated at moderate risk of bias (fig 2).

Lockdown and transmission of SARS-CoV-2

Four studies assessed universal lockdown and transmission of SARS-CoV-2 during the first few months of the pandemic (table 2). The decrease in reproductive number (R0) ranged from 1.27 in Italy (pre-intervention 2.03, post-intervention 0.76)39 to 2.09 in India (pre-intervention 3.36, post-intervention 1.27),64 and 3.97 in China (pre-intervention 4.95, post-intervention 0.98).33 A natural experiment from the US reported that lockdown was associated with an 11% reduction in transmission of SARS-CoV-2 (relative risk 0.89, 95% confidence interval 0.88 to 0.91).40 All the studies were rated at low risk of bias33 39 to moderate risk40 64 (fig 2).

Travel related measures

Restricted travel and border closures

Border closure was assessed in one natural experiment study involving nine African countries (table 3).62 Overall, the countries recorded an increase in the incidence of covid-19 after border closure. These studies concluded that the implementation of border closures within African countries had minimal effect on the incidence of covid-19. The study had important limitations and was rated at serious or critical risk of bias. In the US, a natural experiment study reported that restrictions on travel between states contributed about 11% to a reduction in SARS-CoV-2 transmission (table 3).36 The study was rated at moderate risk of bias (fig 2).
Table 3

Study characteristics and main results from studies that assessed individual travel measures

Reference, countryStudy designPublic health measure Sample sizeOutcome measureStudy durationEffect estimates: conclusionsRisk of bias
Emeto et al,62 AfricaNatural experimentBorder closure9 countriesRt14 Feb-19 Jul 2020See supplementary table for data on all countries: minimal effect on reducing transmission (Rt)*†Serious or critical
Liu et al,58 USANatural experimentInterstate travel restrictions50 statesRt21 Jan-31 May 2020Risk ratio 0.89 (95% confidence interval 0.84 to 0.95): contributed about 11% to reduction in Rt*Moderate
Mitra et al,54 AustraliaRetrospective cohortScreening for fever65 000 peopleDaily growth rate9 Mar-13 May 2020Sensitivity 24%: 86% of cases not detected—poor sensitivity of identifying people with SARS-CoV-2*Moderate

R0=reproductive number; Rt=time varying reproductive number.

Interpretation of findings as reported in the original manuscript.

Not an effective intervention

Study characteristics and main results from studies that assessed individual travel measures R0=reproductive number; Rt=time varying reproductive number. Interpretation of findings as reported in the original manuscript. Not an effective intervention

Entry and exit screening (virus or symptom screening)

One retrospective cohort study assessed screening of symptoms, which involved testing 65 000 people for fever (table 3).54 The study found that screening for fever lacked sensitivity (ranging from 18% to 24%) in detecting people with SARS-CoV-2 infection. This translated to 86% of the population with SARS-CoV-2 remaining undetected when screening for fever. The study was rated at moderate risk of bias (fig 2).

Multiple public health measures

Study characteristics

Overall, 37 studies provided estimates on the effectiveness of multiple public health measures, assessed as a collective group. Studies were mostly conducted in Asia (n=15), the US (n=11), Europe (n=6), Africa (n=4), and South America (n=1). All the studies were observational. The most commonly measured outcome was transmission of disease (ie, measured as reproductive number, growth number, or epidemic doubling time) (n=23), followed by covid-19 incidence (n=19) and covid-19 mortality (n=8). This review attempted to assess the overall effectiveness of the public health intervention packages by reporting the percentage difference in outcome before and after implementation of measures or between regions or countries studied. Eleven of the 37 included studies noted a difference of between 26% and 50% in transmission of SARS-CoV-2 and incidence of covid-19,70 71 72 73 74 75 76 77 78 79 80 nine noted a difference of between 51% and 75% in SARS-CoV-2 transmission, covid-19 incidence, and covid-19 mortality,81 82 83 84 85 86 87 88 89 and 14 noted a difference of more than 75% in transmission of SARS-CoV-2, covid-19 incidence and covid-19 mortality.79 80 89 90 91 92 93 94 95 96 97 98 99 100 For the remaining studies, the overall effectiveness was not assessed owing to a lack of comparators (see supplementary material 3, table 3). Two studies that assessed universal lockdown and physical distancing reported a decrease of between 0% and 25% in SARS-CoV-2 transmission and covid-19 incidence.79 101 Studies that included school and workplace closures,91 95 96 isolation or stay at home measures,80 94 or a combination of both79 89 93 97 98 99 reported decreases of more than 75% in SARS-CoV-2 transmission. Supplementary material 3, table 2 provides detailed information on each study.

Discussion

Worldwide, government and public health organisations are mitigating the spread of SARS-CoV-2 by implementing various public health measures. This systematic review identified a statistically significant reduction in the incidence of covid-19 through the implementation of mask wearing and physical distancing. Handwashing interventions also indicated a substantial reduction in covid-19 incidence, albeit not statistically significant in the adjusted model. As the random effects model tends to underestimate confidence intervals when a meta-analysis includes a small number of individual studies (<5), the adjusted model for handwashing showed a statistically non-significant association in reducing the incidence of covid-19 compared with the unadjusted model. Overall effectiveness of these interventions was affected by clinical heterogeneity and methodological limitations, such as confounding and measurement bias. It was not possible to evaluate the impact of type of face maks (eg, surgical, fabric, N95 respirators) and compliance and frequency of wearing masks owing to a lack of data. Similarly, it was not feasible to assess the differences in effect that different recommendations for physical distancing (ie, 1.5 m, 2m, or 3 m) have as preventive strategies. The effectiveness of measures such as universal lockdowns and closures of businesses and schools for the containment of covid-19 have largely been effective, but depended on early implementation when incidence rates of covid-19 were still low.42 52 58 Only Japan reported no decrease in covid-19 incidence after school closures,44 and other studies found that different public health measures were sometimes implemented simultaneously or soon after one another, thus the results should be interpreted with caution.32 46 56 Isolation or stay at home was an effective measure in reducing the transmission of SARS-CoV-2, but the included studies used results for mobility to assess stay at home or isolation and therefore could have been limited by potential flaws in publicly available phone data,41 58 102 and variations in the enforcement of public health measures in different states or regions were not assessed.55 58 102 Quarantine was found to be as effective in reducing the incidence of covid-19 and transmission of SARS-CoV-2, yet variation in testing and case detection in low income environments was substantial.59 96 98 Another study reported that quarantine was effective in reducing the transmission of SARS-CoV-2 in a cohort with a low prevalence of the virus, yet it is unknown if the same effect would be observed with higher prevalence.34 It was not possible to draw conclusions about the effectiveness of restricted travel and full border closures because the number of empirical studies was insufficient. Single studies identified that border closure in Africa had a minimal effect in reducing SARS-CoV-2 transmission, but the study was assessed as being at high risk of bias.62 Screening for fever was also identified to be ineffective, with only 24% of positive cases being captured by screening.54

Comparison with other studies

Previous literature reviews have identified mask wearing as an effective measure for the containment of SARS-CoV-2103; the caveat being that more high level evidence is required to provide unequivocal support for the effectiveness of the universal use of face masks.104 105 Additional empirical evidence from a recent randomised controlled trial (originally published as a preprint) indicates that mask wearing achieved a 9.3% reduction in seroprevalence of symptomatic SARS-CoV-2 infection and an 11.9% reduction in the prevalence of covid-19-like symptoms.106 Another systematic review showed stronger effectiveness with the use of N95, or similar, respirators than disposable surgical masks,107 and a study evaluating the protection offered by 18 different types of fabric masks found substantial heterogeneity in protection, with the most effective mask being multilayered and tight fitting.108 However, transmission of SARS-CoV-2 largely arises in hospital settings in which full personal protective measures are in place, which suggests that when viral load is at its highest, even the best performing face masks might not provide adequate protection.51 Additionally, most studies that assessed mask wearing were prone to important confounding bias, which might have altered the conclusions drawn from this review (ie, effect estimates might have been underestimated or overestimated or can be related to other measures that were in place at the time the studies were conducted). Thus, the extent of such limitations on the conclusions drawn remain unknown. A 2020 rapid review concluded that quarantine is largely effective in reducing the incidence of covid-19 and covid-19 mortality. However, uncertainty over the magnitude of such an effect still remains,109 with enhanced management of quality quarantine facilities for improved effective control of the epidemics urgently needed.110 In addition, findings on the application of school and workplace closures are still inconclusive. Policy makers should be aware of the ambiguous evidence when considering school closures, as other potentially less disruptive physical distancing interventions might be more appropriate.21 Numerous findings from studies on the efficacy of school closures showed that the risk of transmission within the educational environment often strongly depends on the incidence of covid-19 in the community, and that school closures are most successfully associated with control of SARS-CoV-2 transmission when other mitigation strategies are in place in the community.111 112 113 114 115 116 117 School closures have been reported to be disruptive to students globally and are likely to impair children’s social, psychological, and educational development118 119 and to result in loss of income and productivity in adults who cannot work because of childcare responsibilities.120 Speculation remains as how best to implement physical distancing measures.121 Studies that assess physical distancing measures might interchangeably study physical distancing with lockdown35 52 56 64 and other measures and thus direct associations are difficult to assess. Empirical evidence from restricted travel and full border closures is also limited, as it is almost impossible to study these strategies as single measures. Current evidence from a recent narrative literature review suggested that control of movement, along with mandated quarantine, travel restrictions, and restricting nationals from entering areas of high infection, are effective measures, but only with good compliance.122 A narrative literature review of travel bans, partial lockdowns, and quarantine also suggested effectiveness of these measures,123 and another rapid review further supported travel restrictions and cross border restrictions to stop the spread of SARS-CoV-2.124 It was impossible to make such observations in the current review because of limited evidence. A German review, however, suggested that entry, exit, and symptom screening measures to prevent transmission of SARS-CoV-2 are not effective at detecting a meaningful proportion of cases,125 and another review using real world data from multiple countries found that border closures had minimal impact on the control of covid-19.126 Although universal lockdowns have shown a protective effect in lowering the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality, these measures are also disruptive to the psychosocial and mental health of children and adolescents,127 global economies,128 and societies.129 Partial lockdowns could be an alternative, as the associated effectiveness can be high,125 especially when implemented early in an outbreak,85 and such measures would be less disruptive to the general population. It is important to also consider numerous sociopolitical and socioeconomic factors that have been shown to increase SARS-CoV-2 infection130 131 and covid-19 mortality.132 Immigration status,82 economic status,81 101 and poverty and rurality98 can influence individual and community compliance with public health measures. Poverty can impact the ability of communities to physically distance,133 especially in crowded living environments,134 135 as well as reduce access to personal protective measures.134 135 A recent study highlights that “a one size fits all” approach to public health measures might not be effective at reducing the spread of SARS-CoV-2 in vulnerable communities136 and could exacerbate social and economic inequalities.135 137 As such, a more nuanced and community specific approach might be required. Even though screening is highly recommended by WHO138 because a proportion of patients with covid-19 can be asymptomatic,138 screening for symptoms might miss a larger proportion of the population with covid-19. Hence, temperature screening technologies might need to be reconsidered and evaluated for cost effectiveness, given such measures are largely depended on symptomatic fever cases.

Strengths and limitations of this review

The main strength of this systematic review was the use of a comprehensive search strategy to identify and select studies for review and thereby minimise selection bias. A clinical epidemiologist developed the search strategy, which was validated by two senior medical librarians. This review followed a comprehensive appraisal process that is recommended by the Cochrane Collaboration31 to assess the effectiveness of public health measures, with specifically validated tools used to independently and individually assess the risk of bias in each study by study design. This review has some limitations. Firstly, high quality evidence on SARS CoV-2 and the effectiveness of public health measures is still limited, with most studies having different underlying target variables. Secondly, information provided in this review is based on current evidence, so will be modified as additional data become available, especially from more prospective and randomised studies. Also, we excluded studies that did not provide certainty over the effect measure, which might have introduced selection bias and limited the interpretation of effectiveness. Thirdly, numerous studies measured interventions only once and others multiple times over short time frames (days v month, or no timeframe). Additionally, the meta-analytical portion of this study was limited by significant heterogeneity observed across studies, which could neither be explored nor explained by subgroup analyses or meta-regression. Finally, we quantitatively assessed only publications that reported individual measures; studies that assessed multiple measures simultaneously were narratively analysed with a broader level of effectiveness (see supplementary material 3, table 3). Also, we excluded studies in languages other than English.

Methodological limitations of studies included in the review

Several studies failed to define and assess for potential confounders, which made it difficult for our review to draw a one directional or causal conclusion. This problem was mainly because we were unable to study only one intervention, given that many countries implemented several public health measures simultaneously; thus it is a challenge to disentangle the impact of individual interventions (ie, physical distancing when other interventions could be contributing to the effect). Additionally, studies measured different primary outcomes and in varied ways, which limited the ability to statistically analyse other measures and compare effectiveness. Further pragmatic randomised controlled trials and natural experiment studies are needed to better inform the evidence and guide the future implementation of public health measures. Given that most measures depend on a population’s adherence and compliance, it is important to understand and consider how these might be affected by factors. A lack of data in the assessed studies meant it was not possible to understand or determine the level of compliance and adherence to any of the measures.

Conclusions and policy implications

Current evidence from quantitative analyses indicates a benefit associated with handwashing, mask wearing, and physical distancing in reducing the incidence of covid-19. The narrative results of this review indicate an effectiveness of both individual or packages of public health measures on the transmission of SARS-CoV-2 and incidence of covid-19. Some of the public health measures seem to be more stringent than others and have a greater impact on economies and the health of populations. When implementing public health measures, it is important to consider specific health and sociocultural needs of the communities and to weigh the potential negative effects of the public health measures against the positive effects for general populations. Further research is needed to assess the effectiveness of public health measures after adequate vaccination coverage has been achieved. It is likely that further control of the covid-19 pandemic depends not only on high vaccination coverage and its effectiveness but also on ongoing adherence to effective and sustainable public health measures. Public health measures have been identified as a preventive strategy for influenza pandemics The effectiveness of such interventions in reducing the transmission of SARS-CoV-2 is unknown The findings of this review suggest that personal and social measures, including handwashing, mask wearing, and physical distancing are effective at reducing the incidence of covid-19 More stringent measures, such as lockdowns and closures of borders, schools, and workplaces need to be carefully assessed by weighing the potential negative effects of these measures on general populations Further research is needed to assess the effectiveness of public health measures after adequate vaccination coverage
  123 in total

1.  The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China.

Authors:  Hien Lau; Veria Khosrawipour; Piotr Kocbach; Agata Mikolajczyk; Justyna Schubert; Jacek Bania; Tanja Khosrawipour
Journal:  J Travel Med       Date:  2020-05-18       Impact factor: 8.490

2.  Effectiveness of contact tracing and quarantine on reducing COVID-19 transmission: a retrospective cohort study.

Authors:  R Malheiro; A L Figueiredo; J P Magalhães; P Teixeira; I Moita; M C Moutinho; R B Mansilha; L M Gonçalves; E Ferreira
Journal:  Public Health       Date:  2020-09-29       Impact factor: 2.427

3.  Effectiveness of personal protective health behaviour against COVID-19.

Authors:  Chon Fu Lio; Hou Hon Cheong; Chin Ion Lei; Iek Long Lo; Lan Yao; Chong Lam; Iek Hou Leong
Journal:  BMC Public Health       Date:  2021-04-29       Impact factor: 3.295

4.  Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh.

Authors:  Jason Abaluck; Laura H Kwong; Ashley Styczynski; Stephen P Luby; Ahmed Mushfiq Mobarak; Ashraful Haque; Md Alamgir Kabir; Ellen Bates-Jefferys; Emily Crawford; Jade Benjamin-Chung; Shabib Raihan; Shadman Rahman; Salim Benhachmi; Neeti Zaman Bintee; Peter J Winch; Maqsud Hossain; Hasan Mahmud Reza; Abdullah All Jaber; Shawkee Gulshan Momen; Aura Rahman; Faika Laz Banti; Tahrima Saiha Huq
Journal:  Science       Date:  2022-01-14       Impact factor: 63.714

5.  Real-time estimation of the reproduction number of the novel coronavirus disease (COVID-19) in China in 2020 based on incidence data.

Authors:  Kai Wang; Shi Zhao; Huling Li; Yateng Song; Lei Wang; Maggie H Wang; Zhihang Peng; Hui Li; Daihai He
Journal:  Ann Transl Med       Date:  2020-06

6.  The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2.

Authors:  Vincent Chi-Chung Cheng; Shuk-Ching Wong; Vivien Wai-Man Chuang; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Siddharth Sridhar; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  J Infect       Date:  2020-04-23       Impact factor: 6.072

7.  Effect of the social distancing measures on the spread of COVID-19 in 10 highly infected countries.

Authors:  Tran Phuoc Bao Thu; Pham Nguyen Hong Ngoc; Nguyen Minh Hai; Le Anh Tuan
Journal:  Sci Total Environ       Date:  2020-06-22       Impact factor: 10.753

8.  Relationship Between COVID-19 Infection and Risk Perception, Knowledge, Attitude, and Four Nonpharmaceutical Interventions During the Late Period of the COVID-19 Epidemic in China: Online Cross-Sectional Survey of 8158 Adults.

Authors:  Hong Xu; Yong Gan; Daikun Zheng; Bo Wu; Xian Zhu; Chang Xu; Chenglu Liu; Zhou Tao; Yaoyue Hu; Min Chen; Mingjing Li; Zuxun Lu; Jack Chen
Journal:  J Med Internet Res       Date:  2020-11-13       Impact factor: 5.428

9.  Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand.

Authors:  Pawinee Doung-Ngern; Rapeepong Suphanchaimat; Apinya Panjangampatthana; Chawisar Janekrongtham; Duangrat Ruampoom; Nawaporn Daochaeng; Napatchakorn Eungkanit; Nichakul Pisitpayat; Nuengruethai Srisong; Oiythip Yasopa; Patchanee Plernprom; Pitiphon Promduangsi; Panita Kumphon; Paphanij Suangtho; Peeriya Watakulsin; Sarinya Chaiya; Somkid Kripattanapong; Thanawadee Chantian; Emily Bloss; Chawetsan Namwat; Direk Limmathurotsakul
Journal:  Emerg Infect Dis       Date:  2020-09-15       Impact factor: 6.883

10.  Quarantine practices and COVID-19 transmission in a low-resource setting: Experience of Kerala, India.

Authors:  Raman Swathy Vaman; Mathew J Valamparampil; Basil Varghese; Elezebeth Mathews; Muhammed Anwar Valiyapurayilmundakundil; Ramya K Abraham; A V Ramdas; A T Manoj; T S Anish
Journal:  J Family Med Prim Care       Date:  2021-02-27
View more
  72 in total

1.  When and How to Adjust Non-Pharmacological Interventions Concurrent with Booster Vaccinations Against COVID-19 - Guangdong, China, 2022.

Authors:  Guanhao He; Fangfang Zeng; Jianpeng Xiao; Jianguo Zhao; Tao Liu; Jianxiong Hu; Sicong Zhang; Ziqiang Lin; Huaiping Zhu; Dan Liu; Min Kang; Haojie Zhong; Yan Li; Limei Sun; Yuwei Yang; Zhixing Li; Zuhua Rong; Weilin Zeng; Xing Li; Zhihua Zhu; Xiaofeng Liang; Wenjun Ma
Journal:  China CDC Wkly       Date:  2022-03-11

2.  Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant.

Authors:  Wadim Koslow; Martin J Kühn; Sebastian Binder; Margrit Klitz; Daniel Abele; Achim Basermann; Michael Meyer-Hermann
Journal:  PLoS Comput Biol       Date:  2022-05-16       Impact factor: 4.779

Review 3.  [Neuromuscular manifestations in long-COVID syndrome].

Authors:  Helmar C Lehmann
Journal:  Nervenarzt       Date:  2022-07-19       Impact factor: 1.297

4.  Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications.

Authors:  Kiran Ramzan; Sameen Shafiq; Iqra Raees; Zia Ul Mustafa; Muhammad Salman; Amer Hayat Khan; Johanna C Meyer; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-06-09

5.  Positioning primary care as base of health care pyramid.

Authors:  Harish Gupta
Journal:  J Family Med Prim Care       Date:  2022-05-14

6.  Changes in the pattern and disease burden of acute respiratory viral infections before and during the COVID-19 pandemic.

Authors:  Chungmin Park; Donghan Lee; Bryan Inho Kim; Sujin Park; Gyehee Lee; Sangwoo Tak
Journal:  Osong Public Health Res Perspect       Date:  2022-06-30

7.  Living Well as a Muslim through the Pandemic Era-A Qualitative Study in Japan.

Authors:  Ishtiaq Ahmad; Gaku Masuda; Sugishita Tomohiko; Chaudhry Ahmed Shabbir
Journal:  Int J Environ Res Public Health       Date:  2022-05-15       Impact factor: 4.614

8.  Optimal Timing of Non-Pharmaceutical Interventions During an Epidemic.

Authors:  Nick F D Huberts; Jacco J J Thijssen
Journal:  Eur J Oper Res       Date:  2022-06-22       Impact factor: 6.363

9.  Lessons from SARS-CoV-2 in India: A data-driven framework for pandemic resilience.

Authors:  Maxwell Salvatore; Soumik Purkayastha; Lakshmi Ganapathi; Rupam Bhattacharyya; Ritoban Kundu; Lauren Zimmermann; Debashree Ray; Aditi Hazra; Michael Kleinsasser; Sunil Solomon; Ramnath Subbaraman; Bhramar Mukherjee
Journal:  Sci Adv       Date:  2022-06-17       Impact factor: 14.957

10.  Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.

Authors:  Chad D Fibke; Yayuk Joffres; John R Tyson; Caroline Colijn; Naveed Z Janjua; Chris Fjell; Natalie Prystajecky; Agatha Jassem; Hind Sbihi
Journal:  Front Public Health       Date:  2022-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.